Loading clinical trials...

Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT02426658

Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3

This pilot phase II trial studies how well pemetrexed disodium works in treating patients with stage IV non-small cell lung cancer and an Eastern Cooperative Oncology Group (ECOG) performance status o...

Lead sponsor: Wake Forest University Health Sciences•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 2

PALACE: Cemiplimab Trial According to ctDNA Levels

NCT06917573 · Non Small Cell Lung Cancer Metastatic, Lung Diseases, and more

Active Not RecruitingPhase 1

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

NCT02495896 · Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, and more

Active Not Recruiting

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

NCT04056247 · Stage IV Non-small Cell Lung Cancer, Stage IV Malignant Melanoma, and more

WITHDRAWNPhase 1/2

CISH Inactivated TILs in the Treatment of NSCLC

NCT05566223 · Carcinoma, Non-Small-Cell Lung, Metastatic Non Small Cell Lung Cancer, and more

TERMINATEDPhase 1/2

Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer

NCT03559049 · Stage IV Non-small Cell Lung Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 12, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment16

Start dateMay 2015

Last updatedOct 12, 2023

Condition

Stage IV Non-Small Cell Lung Cancer

Locations shown

Comprehensive Cancer Center of Wake Forest University

Winston-Salem, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 12, 2023Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions